Policy paper

VMD Regulatory Science Strategy 2021-2026

Creating a modernised and responsive scientific basis for regulating veterinary medicines.

• From: Veterinary Medicines Directorate
• Published: 29 November 2021

Documents

Regulatory Science Strategy 2021-2026

PDF, 1.25 MB, 15 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Our Regulatory Science Strategy 2021-2026 underpins our mission to protect animal health, public health and the environment and promote animal welfare by assuring the quality, safety and efficacy of veterinary medicines.

By keeping abreast of and anticipating future, technological advances and novel approaches, we will ensure that we are well equipped to address scientific and regulatory challenges and advance the scientific basis underlying the authorisation and regulation of veterinary medicines.

This strategy complements our leading role on antimicrobial resistance (AMR) which is pivotal to inform policy decisions and delivery of the UK’s AMR National Action Plan goals.

In November 2020, we consulted on our thinking, background and drivers for the proposals which formed this strategy and our priorities for the next 5 years.

See our consultation paper and introduction video.

Published 29 November 2021